Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
July 09 2024 - 8:00AM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single molecule protein analysis platform,
today announced it will report financial results for the second
quarter 2024 before market open on Tuesday, July 30, 2024.
The company’s management will webcast a corresponding conference
call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time
to discuss its results, business developments, and outlook. Live
audio of the webcast will be available on the “Investors” section
of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.With its
corporate headquarters in Seattle, Washington and its research and
development headquarters in San Carlos, California, Nautilus is a
development stage life sciences company working to create a
platform technology for quantifying and unlocking the complexity of
the proteome. Nautilus’ mission is to transform the field of
proteomics by democratizing access to the proteome and enabling
fundamental advancements across human health and medicine. To learn
more about Nautilus, visit www.nautilus.bio.
Media Contactpress@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Sep 2023 to Sep 2024